Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adhera Therapeutics
Adhera Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Prestalia
Perindopril arginine
,
Amlodipine besylate
2015-01-21
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
amyotrophic lateral sclerosis
,
falciparum malaria
,
relapsing-remitting multiple sclerosis
,
malaria
,
leukemia
,
myelodysplastic syndromes
,
hematologic neoplasms
,
lymphoma
,
graft vs host disease
,
cough
,
aplastic anemia
,
venous thromboembolism
,
thromboembolism
,
healthy volunteers/patients
,
hip fractures
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
glucose intolerance
,
pharyngitis
,
dengue
,
severe dengue
,
viral hemorrhagic fevers
,
hygiene
,
autonomic nervous system diseases
,
immune system diseases
,
skin diseases
,
eczematous skin diseases
,
hypersensitivity
,
immediate hypersensitivity
,
type 2 diabetes mellitus
,
atopic dermatitis
,
eczema
,
dermatitis
,
acute coronary syndrome
,
kidney diseases
,
chronic kidney failure
Aglatimagene besadenovec
thyroid neoplasms
,
glioblastoma
,
glioma
,
central nervous system neoplasms
,
melanoma
,
colonic neoplasms
,
cholangiocarcinoma
,
chondrosarcoma
,
male genital neoplasms
,
castration-resistant prostatic neoplasms
,
ovarian neoplasms
,
breast neoplasms
,
adenocarcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
pancreatic neoplasms
,
sarcoma
,
prostatic neoplasms
,
neoplasms
,
erectile dysfunction
,
neoplasm metastasis
,
urogenital neoplasms
,
hypersensitivity
,
prostatic hyperplasia
,
hyperplasia
,
lower urinary tract symptoms
Intermedine
prostatic neoplasms
,
breast neoplasms
,
neoplasms
Isoxaflutole
therapeutic equivalency
,
healthy volunteers/patients
,
heart failure
,
cardiovascular diseases
,
heart diseases
,
cardiac arrhythmias
,
laparoscopy
,
growth
,
obesity
,
diet therapy
,
acute lung injury
,
lung injury
,
type 2 diabetes mellitus
,
body weight changes
,
atrial fibrillation
,
stroke
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use